Effects of raloxifene hydrochloride on the endometrium of postmenopausal women
- 1 December 1997
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 177 (6) , 1458-1464
- https://doi.org/10.1016/s0002-9378(97)70091-7
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A controlled trial of raloxifene (LY139481) HCl: Impact on bone turnover and serum lipid profile in healthy postmenopausal womenJournal of Bone and Mineral Research, 1996
- Raloxifene: A selective estrogen receptor modulatorJournal of Bone and Mineral Metabolism, 1994
- Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trialThe Lancet, 1994
- Risk of endometrial cancer after tamoxifen treatment of breast cancerThe Lancet, 1994
- Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.Journal of Clinical Investigation, 1994
- Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal WomenAnnals of Internal Medicine, 1992
- Gynecologic complications associated with long-term adjuvant tamoxifen therapy for breast cancerGynecologic Oncology, 1992
- Morphometric analysis of the human endometrium in relation to peripheral hormone levelsFertility and Sterility, 1982
- THE NORMAL POST-MENOPAUSAL ENDOMETRIUMBJOG: An International Journal of Obstetrics and Gynaecology, 1954
- Dating the Endometrial BiopsyFertility and Sterility, 1950